BI 1015550
BI 1015550 is a pharmaceutical drug with 18 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
17 of 17 finished
0.0%
0 ended early
1
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood
Clinical Trials (18)
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood
A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food
A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood
A Study in Healthy People to Compare How 2 Different Low Dose Formulations of BI 1015550 Are Taken up in the Body
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body
A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
This Study in Healthy Men Tests How Itraconazole Influences the Amount of BI 1015550 in the Blood
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18